COMMON STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY (Tables)
|
3 Months Ended |
Mar. 31, 2022 |
| Equity [Abstract] |
|
| Schedule of Stock Option Activity |
A summary of stock option activity for the three months ended March 31, 2022 is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Shares | | Weighted-Average Exercise Price | | Weighted- Average Remaining Life | | Total Intrinsic Value (in millions) | | Balance at December 31, 2021 | 14,527,468 | | $ | 2.20 | | | 5.37 | | $ | 226 | | | Granted during the period | 4,463,248 | | | 14.15 | | | | | | | Exercised during the period | (1,422,856) | | | 2.47 | | | | | | | Cancelled and forfeited during the period | (81,193) | | | 7.66 | | | | | | | Balance at March 31, 2022 | 17,486,667 | | | $ | 5.21 | | | 5.44 | | $ | 145 | | | Options vested and expected to vest at March 31, 2022 | 17,486,667 | | $ | 5.21 | | | 5.44 | | $ | 145 | | | Options exercisable at March 31, 2022 | 12,442,934 | | $ | 1.92 | | | 4.90 | | $ | 144 | |
|
| Schedule of Activity Related to Time-Based and Market-Based RSUs |
The following table summarizes the activity related to our Time-Based RSUs for the three months ended March 31, 2022: | | | | | | | | | | | | | Number of RSUs | | Weighted- average grant date fair value | | Unvested at December 31, 2021 | 49,428,070 | | | $ | 31.78 | | | Granted | 36,926,801 | | | 13.49 | | | Vested | (4,551,630) | | | 27.65 | | | Forfeited | (4,087,935) | | | 30.07 | | | Unvested at March 31, 2022 | 77,715,306 | | | $ | 23.43 | | The following table summarizes the activity related to our Market-Based RSUs for the three months ended March 31, 2022: | | | | | | | | | | | | | Number of RSUs | | Weighted- average grant date fair value | | Unvested at December 31, 2021 | 58,918,844 | | | $ | 23.50 | | | Granted | — | | | — | | | Vested | (115,264) | | | 2.34 | | | Forfeited | — | | | — | | | Unvested at March 31, 2022 | 58,803,580 | | | $ | 23.54 | |
|
| Schedule of Share-Based Compensation |
The following table presents share-based compensation on our unaudited condensed consolidated statements of operations for the periods indicated: | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | (in millions) | 2021 | | 2022 | | | | | | Brokerage and transaction | $ | — | | | $ | 1 | | | | | | | Technology and development | 1 | | | 82 | | | | | | | Operations | — | | | 4 | | | | | | | Marketing | — | | | 5 | | | | | | | General and administrative | 8 | | | 128 | | | | | | | Total | $ | 9 | | | $ | 220 | | | | | |
|
| Schedule Of Vesting For Awards Outstanding |
Scheduled vesting for awards outstanding as of March 31, 2022, is as follows: | | | | | | | | | | | | | (in millions, except for number of shares) | | | | | | | | | Number of Shares(1) | | Expense | | Remainder of 2022 | 20,911,890 | | | $ | 708 | | | 2023 | 27,019,754 | | | 669 | | | 2024 | 20,776,835 | | | 426 | | | 2025 | 12,895,735 | | | 274 | | | 2026 | 2,348,400 | | | 35 | | | Total | 83,952,614 | | | $ | 2,112 | | (1) Excludes future ESPP shares and Market-Based RSUs for which the share price target has not been met as we cannot forecast the vesting of these shares.
|